國脈科技(002093.SZ):擬購買興銀基金產品
格隆匯8月19日丨國脈科技(002093.SZ)公佈,為進一步提升公司資金使用效率,結合興銀基金產品的綜合表現,公司於2024年8月19日召開第八屆董事會第十八次會議,審議通過《關於購買興銀基金產品暨關聯交易的議案》。經公司投資部門推薦和綜合考察,在第八屆董事會第十五次會議審議的證券投資額度內,公司及子公司購買興銀基金髮行的產品與合作成立集合資產管理計劃的合計餘額不超過(含)1.8億元人民幣,在該餘額內,上述投資金額可循環使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.